Loading provider…
Loading provider…
Internal Medicine Physician in Agoura Hills, CA
NPI: 1356335277Primary Practice Location
AFC Agoura Hills Urgent Care
5825 Kanan Rd, CA
Primary Employer
Rumi Medical Clinic
rumimedicalclinic.com
HQ Phone
Get MD Homayoon's Phone Numberphone_androidMobile
Get MD Homayoon's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
1998 - 2026
PA State Medical License
1997 - 2002
CA State Medical License

American Board of Internal Medicine
Internal Medicine
Albert Einstein Healthcare Network
Residency • Internal Medicine
1996 - 1999
Paris Descartes University Faculty of Medical Science
Medical School
Until 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 354 | 504 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 285 | 286 |
| 3 | 87811Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 191 | 234 |
| 4 | 87804Detection test for influenza virus | 123 | 274 |
| 5 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 120 | 244 |
Authors: Khanlou, H, Eiger, G
Journal: Mayo Clin Proc
Authors: DeJesus, Edwin, Ruane, Peter, McDonald, Cheryl, Garcia, Fernando, Sharma, Shetal, Corales, Roberto, Ravishankar, Jayashree, Khanlou, Homayoun, Shamblaw, David, Ecker, Janet, Ebrahimi, Ramin, Flaherty, John
Journal: HIV Clin Trials
Interaction between atazanavir and fosamprenavir in the treatment of HIV-infected patients.
Authors: Khanlou, Homayoun, Bhatti, Laveeza, Farthing, Charles
Journal: J Acquir Immune Defic Syndr
Lead Sponsor: AIDS Healthcare Foundation
Collaborators: Ganeden Biotech, Inc.
Intervention / Treatment: DRUG: Placebo, DIETARY_SUPPLEMENT: GanedenBC30, GBI-30, PTA-6086